Advertisement
Research Article

Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study

  • Roger Bate,

    Affiliations: Africa Fighting Malaria, Washington, D. C., United States of America, American Enterprise Institute, Washington, D. C., United States of America

    X
  • Philip Coticelli mail,

    pcoticelli@fightingmalaria.org

    Affiliation: Africa Fighting Malaria, Washington, D. C., United States of America

    X
  • Richard Tren,

    Affiliation: Africa Fighting Malaria, Washington, D. C., United States of America

    X
  • Amir Attaran

    Affiliation: Institute of Population Health & Faculties of Law and Medicine, University of Ottawa, Ottawa, Canada

    X
  • Published: May 07, 2008
  • DOI: 10.1371/journal.pone.0002132

About the Authors

Roger Bate, Philip Coticelli, Richard Tren
Africa Fighting Malaria, Washington, D. C., United States of America
Roger Bate
American Enterprise Institute, Washington, D. C., United States of America
Amir Attaran
Institute of Population Health & Faculties of Law and Medicine, University of Ottawa, Ottawa, Canada

Corresponding Author

Email: pcoticelli@fightingmalaria.org

Competing Interests

In the past five years Roger Bate and Amir Attaran received travel grants from pharmaceutical company Novartis, and Amir Attaran received a consulting fee. No funding was received in respect of this research. Amir Attaran also received consulting and/or travel fees from the WHO and World Bank, and is a member of the WHO Global Malaria Programme Technical and Research Advisory Committee. No member of the study team received any funds from a competing interest for the performance of this study.

Author Contributions

Conceived and designed the experiments: RB. Performed the experiments: RB. Analyzed the data: RT PC RB. Wrote the paper: AA RT PC RB.